Q1 Earnings Forecast for JAZZ Issued By HC Wainwright
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – HC Wainwright issued their Q1 2025 earnings estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Monday, March 10th. HC Wainwright analyst O. Livnat forecasts that the specialty pharmaceutical company will post earnings of $3.45 per share for the quarter. HC Wainwright […]
